Sanofi (OTCMKTS:SNYNF) Short Interest Down 42.6% in April

Sanofi (OTCMKTS:SNYNFGet Free Report) was the recipient of a large decrease in short interest in April. As of April 30th, there was short interest totaling 152,194 shares, a decrease of 42.6% from the April 15th total of 265,221 shares. Based on an average daily volume of 7,571 shares, the short-interest ratio is presently 20.1 days.

Sanofi Trading Up 3.5%

OTCMKTS SNYNF opened at $86.40 on Friday. The firm’s 50 day simple moving average is $90.74 and its 200 day simple moving average is $94.52. Sanofi has a 1 year low of $83.17 and a 1 year high of $107.24.

Sanofi Company Profile

(Get Free Report)

Sanofi is a multinational biopharmaceutical company headquartered in Paris, France, specializing in the research, development and manufacturing of prescription medicines, vaccines and consumer healthcare products. With a strategic focus on specialty care, vaccines, and general medicines, Sanofi’s portfolio addresses a broad range of therapeutic areas, including diabetes, cardiovascular disease, oncology, immunology and rare diseases. The company operates through distinct business segments, each dedicated to advancing patient care through innovative therapies and preventive solutions.

In its pharmaceuticals segment, Sanofi develops and markets biologics and small molecules designed to treat chronic and acute conditions.

See Also

Receive News & Ratings for Sanofi Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sanofi and related companies with MarketBeat.com's FREE daily email newsletter.